CCThe Chemours Company
Is it safe?
Mostly sound, with a caveat: insiders buying, but heavy debt (CCC) and big price swings.
Multiple insiders bought with their own money (net +$489K, 90 days to Oct 8, 2026).
Highly leveraged, watch solvency. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -86% · now 51% below its 52-week high.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can CC take a bad year?
The Chemours Company carries $3.20B of net debt at 15.3× EBITDA: a heavy load to carry through a bad year.
Net debt · as at Q2 2026 · over four years of earnings before interest, tax and depreciation, heavy
- Net debt / EBITDA
- 15.3×
Net debt / EBITDA · 13.6× a year ago · the load is going up
- Interest cover
- none
Interest cover · no operating profit to pay the interest bill from
- Annualised volatility
- 64%
Annualised volatility · three times the market's own swing
Details›
- Total debtQ2 2026
- $3.87B
- Cash and short-term investments
- $671M
- Net debt
- $3.20B
- EBITDA, trailing twelve months
- $209M
- Operating profit, trailing twelve months
- −$111M
- Total debt / EBITDA
- 18.5×
- Annualised volatilitytwo years of daily moves
- 64%
- Worst drawdown on file
- −86%
- Below its 52-week high
- 51%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Specialty Chemicals
Ranks #24 of 33 by RyuScore